1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Tablet 1.2.3 Injection 1.3 Market by Application 1.3.1 Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Mild Symptom Patient 1.3.3 Critically Ill Patient 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Specific Antiviral Drugs for COVID-19 Market Perspective (2018-2029) 2.2 Global Specific Antiviral Drugs for COVID-19 Growth Trends by Region 2.2.1 Specific Antiviral Drugs for COVID-19 Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Specific Antiviral Drugs for COVID-19 Historic Market Size by Region (2018-2023) 2.2.3 Specific Antiviral Drugs for COVID-19 Forecasted Market Size by Region (2024-2029) 2.3 Specific Antiviral Drugs for COVID-19 Market Dynamics 2.3.1 Specific Antiviral Drugs for COVID-19 Industry Trends 2.3.2 Specific Antiviral Drugs for COVID-19 Market Drivers 2.3.3 Specific Antiviral Drugs for COVID-19 Market Challenges 2.3.4 Specific Antiviral Drugs for COVID-19 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Revenue Specific Antiviral Drugs for COVID-19 by Players 3.1.1 Global Specific Antiviral Drugs for COVID-19 Revenue by Players (2018-2023) 3.1.2 Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Players (2018-2023) 3.2 Global Specific Antiviral Drugs for COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Global Key Players of Specific Antiviral Drugs for COVID-19, Ranking by Revenue, 2021 VS 2022 VS 2023 3.4 Global Specific Antiviral Drugs for COVID-19 Market Concentration Ratio 3.4.1 Global Specific Antiviral Drugs for COVID-19 Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Specific Antiviral Drugs for COVID-19 Revenue in 2022 3.5 Global Key Players of Specific Antiviral Drugs for COVID-19 Head office and Area Served 3.6 Global Key Players of Specific Antiviral Drugs for COVID-19, Product and Application 3.7 Global Key Players of Specific Antiviral Drugs for COVID-19, Date of Enter into This Industry 3.8 Mergers & Acquisitions, Expansion Plans 4 Specific Antiviral Drugs for COVID-19 Breakdown Data by Type 4.1 Global Specific Antiviral Drugs for COVID-19 Historic Market Size by Type (2018-2023) 4.2 Global Specific Antiviral Drugs for COVID-19 Forecasted Market Size by Type (2024-2029) 5 Specific Antiviral Drugs for COVID-19 Breakdown Data by Application 5.1 Global Specific Antiviral Drugs for COVID-19 Historic Market Size by Application (2018-2023) 5.2 Global Specific Antiviral Drugs for COVID-19 Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Specific Antiviral Drugs for COVID-19 Market Size (2018-2029) 6.2 North America Specific Antiviral Drugs for COVID-19 Market Size by Type 6.2.1 North America Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) 6.2.2 North America Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) 6.2.3 North America Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) 6.3 North America Specific Antiviral Drugs for COVID-19 Market Size by Application 6.3.1 North America Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) 6.3.2 North America Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) 6.3.3 North America Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) 6.4 North America Specific Antiviral Drugs for COVID-19 Market Size by Country 6.4.1 North America Specific Antiviral Drugs for COVID-19 Market Size by Country: 2018 VS 2022 VS 2029 6.4.2 North America Specific Antiviral Drugs for COVID-19 Market Size by Country (2018-2023) 6.4.3 North America Specific Antiviral Drugs for COVID-19 Market Size by Country (2024-2029) 6.4.4 United States 6.4.5 Canada 7 Europe 7.1 Europe Specific Antiviral Drugs for COVID-19 Market Size (2018-2029) 7.2 Europe Specific Antiviral Drugs for COVID-19 Market Size by Type 7.2.1 Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) 7.2.2 Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) 7.2.3 Europe Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) 7.3 Europe Specific Antiviral Drugs for COVID-19 Market Size by Application 7.3.1 Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) 7.3.2 Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) 7.3.3 Europe Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) 7.4 Europe Specific Antiviral Drugs for COVID-19 Market Size by Country 7.4.1 Europe Specific Antiviral Drugs for COVID-19 Market Size by Country: 2018 VS 2022 VS 2029 7.4.2 Europe Specific Antiviral Drugs for COVID-19 Market Size by Country (2018-2023) 7.4.3 Europe Specific Antiviral Drugs for COVID-19 Market Size by Country (2024-2029) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 China 8.1 China Specific Antiviral Drugs for COVID-19 Market Size (2018-2029) 8.2 China Specific Antiviral Drugs for COVID-19 Market Size by Type 8.2.1 China Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) 8.2.2 China Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) 8.2.3 China Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) 8.3 China Specific Antiviral Drugs for COVID-19 Market Size by Application 8.3.1 China Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) 8.3.2 China Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) 8.3.3 China Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Specific Antiviral Drugs for COVID-19 Market Size (2018-2029) 9.2 Asia Specific Antiviral Drugs for COVID-19 Market Size by Type 9.2.1 Asia Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) 9.2.2 Asia Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) 9.2.3 Asia Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) 9.3 Asia Specific Antiviral Drugs for COVID-19 Market Size by Application 9.3.1 Asia Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) 9.3.2 Asia Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) 9.3.3 Asia Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) 9.4 Asia Specific Antiviral Drugs for COVID-19 Market Size by Region 9.4.1 Asia Specific Antiviral Drugs for COVID-19 Market Size by Region: 2018 VS 2022 VS 2029 9.4.2 Asia Specific Antiviral Drugs for COVID-19 Market Size by Region (2018-2023) 9.4.3 Asia Specific Antiviral Drugs for COVID-19 Market Size by Region (2024-2029) 9.4.4 Japan 9.4.5 South Korea 9.4.6 China Taiwan 9.4.7 Southeast Asia 9.4.8 India 9.4.9 Australia 10 Middle East, Africa, and Latin America 10.1 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size (2018-2029) 10.2 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Type 10.2.1 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) 10.2.2 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) 10.2.3 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) 10.3 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Application 10.3.1 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) 10.3.2 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) 10.3.3 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) 10.4 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Country 10.4.1 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Country: 2018 VS 2022 VS 2029 10.4.2 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Country (2018-2023) 10.4.3 Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Country (2024-2029) 10.4.4 Brazil 10.4.5 Mexico 10.4.6 Turkey 10.4.7 Saudi Arabia 10.4.8 Israel 10.4.9 GCC Countries 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Specific Antiviral Drugs for COVID-19 Introduction 11.1.4 Sanofi Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.1.5 Sanofi Recent Developments 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Specific Antiviral Drugs for COVID-19 Introduction 11.2.4 Novartis Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.2.5 Novartis Recent Developments 11.3 Shanghai Zhongxisanwei 11.3.1 Shanghai Zhongxisanwei Company Details 11.3.2 Shanghai Zhongxisanwei Business Overview 11.3.3 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Introduction 11.3.4 Shanghai Zhongxisanwei Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.3.5 Shanghai Zhongxisanwei Recent Developments 11.4 Teva 11.4.1 Teva Company Details 11.4.2 Teva Business Overview 11.4.3 Teva Specific Antiviral Drugs for COVID-19 Introduction 11.4.4 Teva Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.4.5 Teva Recent Developments 11.5 Zydus Cadila 11.5.1 Zydus Cadila Company Details 11.5.2 Zydus Cadila Business Overview 11.5.3 Zydus Cadila Specific Antiviral Drugs for COVID-19 Introduction 11.5.4 Zydus Cadila Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.5.5 Zydus Cadila Recent Developments 11.6 Mylan 11.6.1 Mylan Company Details 11.6.2 Mylan Business Overview 11.6.3 Mylan Specific Antiviral Drugs for COVID-19 Introduction 11.6.4 Mylan Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.6.5 Mylan Recent Developments 11.7 Apotex 11.7.1 Apotex Company Details 11.7.2 Apotex Business Overview 11.7.3 Apotex Specific Antiviral Drugs for COVID-19 Introduction 11.7.4 Apotex Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.7.5 Apotex Recent Developments 11.8 Advanz Pharma 11.8.1 Advanz Pharma Company Details 11.8.2 Advanz Pharma Business Overview 11.8.3 Advanz Pharma Specific Antiviral Drugs for COVID-19 Introduction 11.8.4 Advanz Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.8.5 Advanz Pharma Recent Developments 11.9 Sun Pharma 11.9.1 Sun Pharma Company Details 11.9.2 Sun Pharma Business Overview 11.9.3 Sun Pharma Specific Antiviral Drugs for COVID-19 Introduction 11.9.4 Sun Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.9.5 Sun Pharma Recent Developments 11.10 Kyung Poong 11.10.1 Kyung Poong Company Details 11.10.2 Kyung Poong Business Overview 11.10.3 Kyung Poong Specific Antiviral Drugs for COVID-19 Introduction 11.10.4 Kyung Poong Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.10.5 Kyung Poong Recent Developments 11.11 Ipca Laboratories 11.11.1 Ipca Laboratories Company Details 11.11.2 Ipca Laboratories Business Overview 11.11.3 Ipca Laboratories Specific Antiviral Drugs for COVID-19 Introduction 11.11.4 Ipca Laboratories Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.11.5 Ipca Laboratories Recent Developments 11.12 Hanlim Pharmaceutical 11.12.1 Hanlim Pharmaceutical Company Details 11.12.2 Hanlim Pharmaceutical Business Overview 11.12.3 Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Introduction 11.12.4 Hanlim Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.12.5 Hanlim Pharmaceutical Recent Developments 11.13 Bristol Laboratories 11.13.1 Bristol Laboratories Company Details 11.13.2 Bristol Laboratories Business Overview 11.13.3 Bristol Laboratories Specific Antiviral Drugs for COVID-19 Introduction 11.13.4 Bristol Laboratories Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.13.5 Bristol Laboratories Recent Developments 11.14 Bayer 11.14.1 Bayer Company Details 11.14.2 Bayer Business Overview 11.14.3 Bayer Specific Antiviral Drugs for COVID-19 Introduction 11.14.4 Bayer Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.14.5 Bayer Recent Developments 11.15 Rising Pharmaceutical 11.15.1 Rising Pharmaceutical Company Details 11.15.2 Rising Pharmaceutical Business Overview 11.15.3 Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Introduction 11.15.4 Rising Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.15.5 Rising Pharmaceutical Recent Developments 11.16 Shanghai Pharma 11.16.1 Shanghai Pharma Company Details 11.16.2 Shanghai Pharma Business Overview 11.16.3 Shanghai Pharma Specific Antiviral Drugs for COVID-19 Introduction 11.16.4 Shanghai Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.16.5 Shanghai Pharma Recent Developments 11.17 Sichuan Sunny Hope 11.17.1 Sichuan Sunny Hope Company Details 11.17.2 Sichuan Sunny Hope Business Overview 11.17.3 Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Introduction 11.17.4 Sichuan Sunny Hope Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.17.5 Sichuan Sunny Hope Recent Developments 11.18 Guangzhou Baiyunshan Guanghua Pharmaceutical 11.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details 11.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview 11.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Introduction 11.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.18.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments 11.19 CSPC Group 11.19.1 CSPC Group Company Details 11.19.2 CSPC Group Business Overview 11.19.3 CSPC Group Specific Antiviral Drugs for COVID-19 Introduction 11.19.4 CSPC Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.19.5 CSPC Group Recent Developments 11.20 KPC Group 11.20.1 KPC Group Company Details 11.20.2 KPC Group Business Overview 11.20.3 KPC Group Specific Antiviral Drugs for COVID-19 Introduction 11.20.4 KPC Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.20.5 KPC Group Recent Developments 11.21 Jinghua Pharmaceutical Group 11.21.1 Jinghua Pharmaceutical Group Company Details 11.21.2 Jinghua Pharmaceutical Group Business Overview 11.21.3 Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Introduction 11.21.4 Jinghua Pharmaceutical Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.21.5 Jinghua Pharmaceutical Group Recent Developments 11.22 Zhongsheng Pharma 11.22.1 Zhongsheng Pharma Company Details 11.22.2 Zhongsheng Pharma Business Overview 11.22.3 Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Introduction 11.22.4 Zhongsheng Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.22.5 Zhongsheng Pharma Recent Developments 11.23 North China Pharmaceutical Group 11.23.1 North China Pharmaceutical Group Company Details 11.23.2 North China Pharmaceutical Group Business Overview 11.23.3 North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Introduction 11.23.4 North China Pharmaceutical Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) 11.23.5 North China Pharmaceutical Group Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029 Table 2. Key Players of Tablet Table 3. Key Players of Injection Table 4. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029 Table 5. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Specific Antiviral Drugs for COVID-19 Market Size by Region (2018-2023) & (US$ Million) Table 7. Global Specific Antiviral Drugs for COVID-19 Market Share by Region (2018-2023) Table 8. Global Specific Antiviral Drugs for COVID-19 Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global Specific Antiviral Drugs for COVID-19 Market Share by Region (2024-2029) Table 10. Specific Antiviral Drugs for COVID-19 Market Trends Table 11. Specific Antiviral Drugs for COVID-19 Market Drivers Table 12. Specific Antiviral Drugs for COVID-19 Market Challenges Table 13. Specific Antiviral Drugs for COVID-19 Market Restraints Table 14. Global Specific Antiviral Drugs for COVID-19 Revenue by Players (2018-2023) & (US$ Million) Table 15. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Players (2018-2023) Table 16. Global Top Specific Antiviral Drugs for COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specific Antiviral Drugs for COVID-19 as of 2022) Table 17. Global Specific Antiviral Drugs for COVID-19 Industry Ranking 2021 VS 2022 VS 2023 Table 18. Global 5 Largest Players Market Share by Specific Antiviral Drugs for COVID-19 Revenue (CR5 and HHI) & (2018-2023) Table 19. Global Key Players of Specific Antiviral Drugs for COVID-19, Headquarters and Area Served Table 20. Global Key Players of Specific Antiviral Drugs for COVID-19, Product and Application Table 21. Global Key Players of Specific Antiviral Drugs for COVID-19, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) & (US$ Million) Table 24. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Type (2018-2023) Table 25. Global Specific Antiviral Drugs for COVID-19 Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Type (2024-2029) Table 27. Global Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) & (US$ Million) Table 28. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Application (2018-2023) Table 29. Global Specific Antiviral Drugs for COVID-19 Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Application (2024-2029) Table 31. North America Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) & (US$ Million) Table 32. North America Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) & (US$ Million) Table 33. North America Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) & (US$ Million) Table 34. North America Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) & (US$ Million) Table 35. North America Specific Antiviral Drugs for COVID-19 Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. North America Specific Antiviral Drugs for COVID-19 Market Size by Country (2018-2023) & (US$ Million) Table 37. North America Specific Antiviral Drugs for COVID-19 Market Size by Country (2024-2029) & (US$ Million) Table 38. Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) & (US$ Million) Table 39. Europe Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) & (US$ Million) Table 40. Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) & (US$ Million) Table 41. Europe Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) & (US$ Million) Table 42. Europe Specific Antiviral Drugs for COVID-19 Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Europe Specific Antiviral Drugs for COVID-19 Market Size by Country (2018-2023) & (US$ Million) Table 44. Europe Specific Antiviral Drugs for COVID-19 Market Size by Country (2024-2029) & (US$ Million) Table 45. China Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) & (US$ Million) Table 46. China Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) & (US$ Million) Table 47. China Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) & (US$ Million) Table 48. China Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) & (US$ Million) Table 49. Asia Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) & (US$ Million) Table 50. Asia Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) & (US$ Million) Table 51. Asia Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) & (US$ Million) Table 52. Asia Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) & (US$ Million) Table 53. Asia Specific Antiviral Drugs for COVID-19 Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029 Table 54. Asia Specific Antiviral Drugs for COVID-19 Market Size by Region (2018-2023) & (US$ Million) Table 55. Asia Specific Antiviral Drugs for COVID-19 Market Size by Region (2024-2029) & (US$ Million) Table 56. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Type (2018-2023) & (US$ Million) Table 57. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Type (2024-2029) & (US$ Million) Table 58. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Application (2018-2023) & (US$ Million) Table 59. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Application (2024-2029) & (US$ Million) Table 60. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029 Table 61. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Country (2018-2023) & (US$ Million) Table 62. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size by Country (2024-2029) & (US$ Million) Table 63. Sanofi Company Details Table 64. Sanofi Business Overview Table 65. Sanofi Specific Antiviral Drugs for COVID-19 Product Table 66. Sanofi Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 67. Sanofi Recent Developments Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Specific Antiviral Drugs for COVID-19 Product Table 71. Novartis Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 72. Novartis Recent Developments Table 73. Shanghai Zhongxisanwei Company Details Table 74. Shanghai Zhongxisanwei Business Overview Table 75. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Product Table 76. Shanghai Zhongxisanwei Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 77. Shanghai Zhongxisanwei Recent Developments Table 78. Teva Company Details Table 79. Teva Business Overview Table 80. Teva Specific Antiviral Drugs for COVID-19 Product Table 81. Teva Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 82. Teva Recent Developments Table 83. Zydus Cadila Company Details Table 84. Zydus Cadila Business Overview Table 85. Zydus Cadila Specific Antiviral Drugs for COVID-19 Product Table 86. Zydus Cadila Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 87. Zydus Cadila Recent Developments Table 88. Mylan Company Details Table 89. Mylan Business Overview Table 90. Mylan Specific Antiviral Drugs for COVID-19 Product Table 91. Mylan Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 92. Mylan Recent Developments Table 93. Apotex Company Details Table 94. Apotex Business Overview Table 95. Apotex Specific Antiviral Drugs for COVID-19 Product Table 96. Apotex Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 97. Apotex Recent Developments Table 98. Advanz Pharma Company Details Table 99. Advanz Pharma Business Overview Table 100. Advanz Pharma Specific Antiviral Drugs for COVID-19 Product Table 101. Advanz Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 102. Advanz Pharma Recent Developments Table 103. Sun Pharma Company Details Table 104. Sun Pharma Business Overview Table 105. Sun Pharma Specific Antiviral Drugs for COVID-19 Product Table 106. Sun Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 107. Sun Pharma Recent Developments Table 108. Kyung Poong Company Details Table 109. Kyung Poong Business Overview Table 110. Kyung Poong Specific Antiviral Drugs for COVID-19 Product Table 111. Kyung Poong Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 112. Kyung Poong Recent Developments Table 113. Ipca Laboratories Company Details Table 114. Ipca Laboratories Business Overview Table 115. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Product Table 116. Ipca Laboratories Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 117. Ipca Laboratories Recent Developments Table 118. Hanlim Pharmaceutical Company Details Table 119. Hanlim Pharmaceutical Business Overview Table 120. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Product Table 121. Hanlim Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 122. Hanlim Pharmaceutical Recent Developments Table 123. Bristol Laboratories Company Details Table 124. Bristol Laboratories Business Overview Table 125. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Product Table 126. Bristol Laboratories Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 127. Bristol Laboratories Recent Developments Table 128. Bayer Company Details Table 129. Bayer Business Overview Table 130. Bayer Specific Antiviral Drugs for COVID-19 Product Table 131. Bayer Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 132. Bayer Recent Developments Table 133. Rising Pharmaceutical Company Details Table 134. Rising Pharmaceutical Business Overview Table 135. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Product Table 136. Rising Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 137. Rising Pharmaceutical Recent Developments Table 138. Shanghai Pharma Company Details Table 139. Shanghai Pharma Business Overview Table 140. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Product Table 141. Shanghai Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 142. Shanghai Pharma Recent Developments Table 143. Sichuan Sunny Hope Company Details Table 144. Sichuan Sunny Hope Business Overview Table 145. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Product Table 146. Sichuan Sunny Hope Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 147. Sichuan Sunny Hope Recent Developments Table 148. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details Table 149. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 150. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Product Table 151. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 152. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments Table 153. CSPC Group Company Details Table 154. CSPC Group Business Overview Table 155. CSPC Group Specific Antiviral Drugs for COVID-19 Product Table 156. CSPC Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 157. CSPC Group Recent Developments Table 158. KPC Group Company Details Table 159. KPC Group Business Overview Table 160. KPC Group Specific Antiviral Drugs for COVID-19 Product Table 161. KPC Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 162. KPC Group Recent Developments Table 163. Jinghua Pharmaceutical Group Company Details Table 164. Jinghua Pharmaceutical Group Business Overview Table 165. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product Table 166. Jinghua Pharmaceutical Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 167. Jinghua Pharmaceutical Group Recent Developments Table 168. Zhongsheng Pharma Company Details Table 169. Zhongsheng Pharma Business Overview Table 170. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Product Table 171. Zhongsheng Pharma Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 172. Zhongsheng Pharma Recent Developments Table 173. North China Pharmaceutical Group Company Details Table 174. North China Pharmaceutical Group Business Overview Table 175. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product Table 176. North China Pharmaceutical Group Revenue in Specific Antiviral Drugs for COVID-19 Business (2018-2023) & (US$ Million) Table 177. North China Pharmaceutical Group Recent Developments Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million) Figure 2. Global Specific Antiviral Drugs for COVID-19 Market Share by Type: 2022 VS 2029 Figure 3. Tablet Features Figure 4. Injection Features Figure 5. Global Specific Antiviral Drugs for COVID-19 Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million) Figure 6. Global Specific Antiviral Drugs for COVID-19 Market Share by Application: 2022 VS 2029 Figure 7. Mild Symptom Patient Case Studies Figure 8. Critically Ill Patient Case Studies Figure 9. Specific Antiviral Drugs for COVID-19 Report Years Considered Figure 10. Global Specific Antiviral Drugs for COVID-19 Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 11. Global Specific Antiviral Drugs for COVID-19 Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 12. Global Specific Antiviral Drugs for COVID-19 Market Share by Region: 2022 VS 2029 Figure 13. Global Specific Antiviral Drugs for COVID-19 Market Share by Players in 2022 Figure 14. Global Top Specific Antiviral Drugs for COVID-19 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specific Antiviral Drugs for COVID-19 as of 2022) Figure 15. The Top 10 and 5 Players Market Share by Specific Antiviral Drugs for COVID-19 Revenue in 2022 Figure 16. North America Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 17. North America Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) Figure 18. North America Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) Figure 19. North America Specific Antiviral Drugs for COVID-19 Market Share by Country (2018-2029) Figure 20. United States Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Canada Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe Specific Antiviral Drugs for COVID-19 Market Size YoY (2018-2029) & (US$ Million) Figure 23. Europe Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) Figure 24. Europe Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) Figure 25. Europe Specific Antiviral Drugs for COVID-19 Market Share by Country (2018-2029) Figure 26. Germany Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. France Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. U.K. Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Italy Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Russia Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Nordic Countries Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. China Specific Antiviral Drugs for COVID-19 Market Size YoY (2018-2029) & (US$ Million) Figure 33. China Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) Figure 34. China Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) Figure 35. Asia Specific Antiviral Drugs for COVID-19 Market Size YoY (2018-2029) & (US$ Million) Figure 36. Asia Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) Figure 37. Asia Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) Figure 38. Asia Specific Antiviral Drugs for COVID-19 Market Share by Region (2018-2029) Figure 39. Japan Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. South Korea Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. China Taiwan Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Southeast Asia Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. India Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Australia Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Size YoY (2018-2029) & (US$ Million) Figure 46. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Share by Type (2018-2029) Figure 47. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Share by Application (2018-2029) Figure 48. Middle East, Africa, and Latin America Specific Antiviral Drugs for COVID-19 Market Share by Country (2018-2029) Figure 49. Brazil Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 50. Mexico Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 51. Turkey Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 52. Saudi Arabia Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 53. Israel Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 54. GCC Countries Specific Antiviral Drugs for COVID-19 Market Size YoY Growth (2018-2029) & (US$ Million) Figure 55. Sanofi Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 56. Novartis Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 57. Shanghai Zhongxisanwei Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 58. Teva Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 59. Zydus Cadila Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 60. Mylan Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 61. Apotex Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 62. Advanz Pharma Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 63. Sun Pharma Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 64. Kyung Poong Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 65. Ipca Laboratories Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 66. Hanlim Pharmaceutical Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 67. Bristol Laboratories Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 68. Bayer Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 69. Rising Pharmaceutical Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 70. Shanghai Pharma Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 71. Sichuan Sunny Hope Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 72. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 73. CSPC Group Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 74. KPC Group Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 75. Jinghua Pharmaceutical Group Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 76. Zhongsheng Pharma Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 77. North China Pharmaceutical Group Revenue Growth Rate in Specific Antiviral Drugs for COVID-19 Business (2018-2023) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Sanofi Novartis Shanghai Zhongxisanwei Teva Zydus Cadila Mylan Apotex Advanz Pharma Sun Pharma Kyung Poong Ipca Laboratories Hanlim Pharmaceutical Bristol Laboratories Bayer Rising Pharmaceutical Shanghai Pharma Sichuan Sunny Hope Guangzhou Baiyunshan Guanghua Pharmaceutical CSPC Group KPC Group Jinghua Pharmaceutical Group Zhongsheng Pharma North China Pharmaceutical Group